Searchable abstracts of presentations at key conferences in endocrinology

ea0059p120 | Neoplasia, cancer & late effects | SFEBES2018

Progestins used in menopausal hormone therapy is not a ‘one-size-fits-all’ for breast cancer risk

Toit Renate Louw Du , Africander Donita

Women worldwide are using progestins in combination with an estrogen to relieve menopausal symptoms. Although the progestin component of menopausal hormone therapies is effective in terms of preventing estrogen-induced endometrial cancer, it has been associated with an increased risk of developing invasive breast cancer. Notably, most studies investigating an association between progestins and breast cancer, have examined older progestins such as medroxyprogesterone acetate, n...